AzTrials
AzTrials

Alcohol Use DisorderNCT04923256

AAT-APP+: A Novel Brain-training App to Reduce Drinking

A study testing AAT-APP: A novel smart-phone approach-avoidance bias modification intervention in people with Alcohol Use Disorder, run by Turning Point at 1 site in Australia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study will explore the feasibility, acceptability, and preliminary effectiveness of a smart phone delivered form of cognitive training intervention (Approach Bias Modification (ABM)) in a non-clinical community sample of middle to older adults (>55 years) reporting hazardous alcohol use in a pilot randomised… Read more about this study

Who is it for?
Ages 55 years and older
Conditions the study is for
Alcohol Use Disorder
What is being tested?
AAT-APP: A novel smart-phone approach-avoidance bias modification intervention
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
188 participants
Where
1 siteAustralia
Study dates
30 Jun 2022to 1 Mar 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 55 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adults aged 55+ years
  • Score 8 or higher on the Alcohol Use Disorders Identification Test (indicates 'hazardous' levels of alcohol use).
  • Access to an Android or Apple smart phone and Australian contact number
  • Wish to reduce their drinking
  • Live within the Eastern Health Primary and Secondary Catchment (see map below)

Who cannot join

  • Under age 55
  • Not concerned about their drinking
  • Do not wish to reduce their alcohol use in the next 4-6 weeks
  • Do not reside with the appropriate catchment will be excluded.
  • Experiencing severe alcohol problems likely to need professional treatment (i.e. presence of withdrawal symptoms in the past year)

Trial locations and contacts

1 site in 1 country.

Australia1 site
  • Turning Point

    Richmond, Victoria, 3121

Other trials in Australia

About this study

Official title: AAT-APP+: A Pilot RCT of a Novel Smart-phone App to Reduce Alcohol Consumption Among Middle to Older Adults in the Eastern Health Community

This study will explore the feasibility, acceptability, and preliminary effectiveness of a smart phone delivered form of cognitive training intervention (Approach Bias Modification (ABM)) in a non-clinical community sample of middle to older adults (>55 years) reporting hazardous alcohol use in a pilot randomised controlled trial (RCT). This app is called AAT-APP+

Read the detailed description

Alcohol use in older adults is of particular concern, with the 55-74 year old cohort most likely to exceed lifetime alcohol risk. Approach Bias Modification (ABM) is a form of computerised cognitive training that is an efficacious intervention for alcohol use disorder. Previous studies are limited in that the stimuli are not personalised, nor are interventions readily accessible to non-treatment seeking problem drinkers. This has led to the development of a world-first, smart phone version of ABM called AAT-APP+

The current study aims to explore the feasibility, acceptability, and preliminary effectiveness of AAT-APP+ in reducing alcohol consumption and cravings in a pilot RCT with a non-clinical community sample of 100 older adults (aged 55+ years) reporting hazardous alcohol use (i.e. a score of 8+ on the AUDIT), recruited via targeted advertising. Participants in active training will upload (or select pre-selected) photos of beverages and meaningful activities, which will form the 'avoid' and 'approach' stimuli, respectively, then complete two training sessions per week for four weeks, with results compared to controls. AAT-APP+ holds promise as an innovate, cost-effective, and remotely accessible adjunctive support tool.

Being tested
AAT-APP: A novel smart-phone approach-avoidance bias modification intervention, Sham training control
Keywords
Alcohol, Intervention, Cognitive Bias Modification, Mobile Health Intervention, Approach Bias
Medical subject headings
Alcoholism

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AAT-APP: A novel smart-phone approach-avoidance bias modification interventionBehavioural

    Participants allocated to the intervention group will be required to upload photos of drinks they wish to avoid, as well as activities they wish to engage in more, and be trained to avoid and approach by repeatedly 'swiping' images away from and towards themselves, respectively.

  • Sham training controlBehavioural

    Complete an AAT on a weekly basis for four weeks

Study groups in NCT04923256
Study groupRoleWhat they receive
Experimental: Approach Bias ModificationExperimentalParticipants will complete 2 x 5-7 min training sessions of approach bias modification for the period of four weeks
Receives: Behavioral: AAT-APP: A novel smart-phone approach-avoidance bias modification intervention
Control: Minimal interventionActive comparatorParticipants will complete a standardised alcohol approach-avoidance training task (AAT) on a weekly basis for four weeks.
Receives: Behavioral: Sham training control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in number of standard drinks past week

    Change from baseline in number of standard drinks at 4-weeks

    Measured: Change from baseline standard drinks at 4-weeks

Secondary outcomes (16)
  1. Change in number of drinking days past week

    Change from baseline in number of drinking days at 4-weeks

    Measured: Change from baseline drinking days at 4-weeks

  2. Change in number of standard drinks consumed in the past week throughout the 4-week training program

    Change from baseline in number of standard drinks at the end of each week of training (i.e. week 1, week 2, week 3)

    Measured: Change from baseline standard drinks consumed in the week prior to training compared to each week of training (i.e. week 1, week 2, week 3).

  3. Change in number of drinking days past week throughout the 4-week training program

    Change from baseline in the number of drinking days at the end of each week of training (i.e. week 1, week 2, week 3)

    Measured: Change from baseline number of drinking days in the week prior to training compared to each week of training (i.e. week 1, week 2, week 3).

  4. Change in number of drinking days at follow up

    Change from baseline in the number of drinking days at 8-weeks

    Measured: Change from baseline number of drinking days at 8-weeks

  5. Craving Frequency Score (as measured by the Craving Experience Questionnaire, Frequency)

    Change from baseline craving, as measured by the Craving Experience Questionnaire, at 4-weeks. The Craving Experience Questionnaire - frequency consists of an 11-point visual analogue scale, anchored 0 = not at all, to 10 = extremely/constantly, assessing craving frequency, whereby higher scores are suggestive of greater craving frequency

    Measured: Change from baseline craving frequency at 4-weeks

  6. Craving Frequency Score (as measured by the Craving Experience Questionnaire, Frequency, Follow up)

    Change from baseline craving, as measured by the Craving Experience Questionnaire, at 8-weeks. The Craving Experience Questionnaire - frequency consists of an 11-point visual analogue scale, anchored 0 = not at all, to 10 = extremely/constantly, assessing craving frequency, whereby higher scores are suggestive of greater craving frequency

    Measured: Change from baseline craving frequency at 8-weeks

  7. Approach-avoidance behaviours (alcohol approach avoidance questionnaire)

    Change from baseline in self-report of approach and avoidance towards alcohol, as measured by the alcohol approach avoidance questionnaire, at 4-weeks. This is a 20-item self report measure with two primary dimensions of alcohol craving (i.e. approach and avoidance), where higher scores are suggestive of greater approach or avoidance behaviours (rated on a 9-point scale, 0 = not at all, 8 = very strongly).

    Measured: Change from baseline approach-avoidance behaviours at 4-weeks

  8. Approach-avoidance behaviours (alcohol approach avoidance questionnaire) at follow up

    Change from baseline in self-report of approach and avoidance towards alcohol, as measured by the alcohol approach avoidance questionnaire, at 8-weeks. This is a 20-item self report measure with two primary dimensions of alcohol craving (i.e. approach and avoidance), where higher scores are suggestive of greater approach or avoidance behaviours (rated on a 9-point scale, 0 = not at all, 8 = very strongly).

    Measured: Change from baseline approach-avoidance behaviours at 8-weeks

  9. Approach-avoidance behaviours (approach avoidance task)

    Change in alcohol approach/avoidance behaviours from baseline at 4-weeks, as calculated by([reaction time for pushing alcohol stimuli] - [reaction time for pulling alcohol related stimuli]) - ([reaction time for pushing neutral objects] - [reaction time for pulling neutral objects]). Higher positive values indicate a tendency to approach alcohol faster (i.e. faster reaction times for pulling as opposed to pushing), whereas negative values indicate a tendency to avoid alcohol (i.e. slower reactions times for pulling compared to pushing alcohol).

    Measured: Change in alcohol approach/avoidance from baseline at 4-weeks

  10. Change in quality of life, as measured by the Australian Treatment Outcomes Profile Questionnaire

    Change in self report of quality of life from baseline, as measured by the quality of life items from the Australian Treatment Outcomes Profile, at 4-weeks. This is a score ranging from 0-10, whereby higher scores are indicative of greater quality of life.

    Measured: Change in quality of life from baseline at 4-weeks

  11. Change in quality of life, as measured by the Australian Treatment Outcomes Profile Questionnaire at follow up

    Change in self report of quality of life from baseline, as measured by the quality of life items from the Australian Treatment Outcomes Profile, at 8-weeks. This is a score ranging from 0-10, whereby higher scores are indicative of greater quality of life.

    Measured: Change in quality of life from baseline at 8-weeks

  12. Change in subjective cognitive concerns

    Change from baseline in subjective ratings of cognitive concerns, as measured by responses to the question "How concerned are you about changes in your thinking, attention, or memory skills", at 4 weeks. Participants will respond on a 5-point visual analogue scale ranging from 0 = not at all to 5 = extremely concerned, whereby higher scores indicate a greater degree of concern in relation to cognition

    Measured: Change from baseline in subjective cognitive concerns at 4-weeks

  13. Change in subjective cognitive concerns at follow up

    Change from baseline in subjective ratings of cognitive concerns, as measured by responses to the question "How concerned are you about changes in your thinking, attention, or memory skills", at 8 weeks. Participants will respond on a 5-point visual analogue scale ranging from 0 = not at all to 5 = extremely concerned, whereby higher scores indicate a greater degree of concern in relation to cognition

    Measured: Change from baseline in subjective cognitive concerns at 8-weeks

  14. Change in number of standard drinks at follow up

    Change from baseline in number of drinking days at 8 weeks

    Measured: Change from baseline in number of drinking days at 8 weeks

  15. Change in severity of alcohol dependence, as measured by the Severity of Dependence Scale

    Change from baseline in severity of alcohol dependence, as measured by the Severity of Dependence Scale, at 4 weeks. Participants respond to five items on a 4-point scale (each scored from 0-3), with total scores ranging from 0-15 where higher scores indicate greater severity of alcohol dependence.

    Measured: Change in severity of alcohol dependence at 4-weeks

  16. Change in severity of alcohol dependence (SDS) at follow up

    Change from baseline in severity of alcohol dependence, as measured by the Severity of Dependence Scale, at 8-weeks. Participants respond to five items on a 4-point scale (each scored from 0-3), with total scores ranging from 0-15 where higher scores indicate greater severity of alcohol dependence.

    Measured: Change in severity of alcohol dependence at 8-weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jun 2021
  2. Study start30 Jun 2022
  3. Primary completion1 Apr 2023
  4. Study completion1 Mar 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomised controlled trial
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
188 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04923256
Sponsor's protocol ID
73140
Status last verified
Jul 2022
First submitted
11 May 2021
Last updated
1 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: A layman summary of the research findings will be made available on the Turning Point website. Participants are told in the explanatory statement that if they would like to be informed of the research findings directly, they will need to contact the researchers via email. Should participants request results of research, this will be in aggregate form.

Questions about this trial

What is this clinical trial studying?

A study testing AAT-APP: A novel smart-phone approach-avoidance bias modification intervention in people with Alcohol Use Disorder, run by Turning Point at 1 site in Australia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Australia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in number of standard drinks past week (time frame: Change from baseline standard drinks at 4-weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Aug 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in